During the last three months, 5 analysts shared their evaluations of Guardant Health (NASDAQ:GH), revealing diverse outlooks from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 0 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 2 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $38.8, a high estimate of $45.00, and a low estimate of $30.00. Highlighting a 17.8% decrease, the current average has fallen from the previous average price target of $47.20.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Guardant Health among financial experts becomes...
Login or create a forever free account to read this news
Sign up/Log in